These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32212180)

  • 1. Ischemic ulcers of the toes secondary to Raynaud's phenomenon in a child successfully treated with botulinum toxin.
    Quintana Castanedo L; Feito Rodríguez M; Maseda Pedrero R; Chiloeches Fernández C; de Lucas Laguna R
    Pediatr Dermatol; 2020 Jul; 37(4):681-683. PubMed ID: 32212180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
    Habib SM; Brenninkmeijer EEA; Vermeer MH; de Vries-Bouwstra JK; Velthuis PJ
    Dermatol Ther; 2020 Nov; 33(6):e14182. PubMed ID: 32794364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toes.
    Dhaliwal K; Griffin M; Denton CP; Butler PEM
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29525756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience.
    Nagarajan M; McArthur P
    Rheumatol Int; 2021 May; 41(5):943-949. PubMed ID: 32447423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
    Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
    J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Botulinum Toxin Type A and its Potential Effect on Exacerbated Raynaud's Phenomenon in Hospitalized Scleroderma Patients.
    Seyedmardani SM; Aghdashi MA; Soltani S; Zonouz GK
    Curr Rheumatol Rev; 2022; 18(1):48-57. PubMed ID: 34636314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case series.
    Dhaliwal K; Griffin MF; Salinas S; Howell K; Denton CP; Butler PEM
    Clin Rheumatol; 2019 Dec; 38(12):3669-3676. PubMed ID: 31482318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
    Neumeister MW
    J Hand Surg Am; 2010 Dec; 35(12):2085-92. PubMed ID: 21134617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in the management of primary and secondary Raynaud's phenomenon.
    Ennis D; Ahmad Z; Anderson MA; Johnson SR
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101684. PubMed ID: 33965340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon.
    Fregene A; Ditmars D; Siddiqui A
    J Hand Surg Am; 2009 Mar; 34(3):446-52. PubMed ID: 19258141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
    Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
    Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment.
    Zhao H; Lian Y
    Australas J Dermatol; 2015 Aug; 56(3):202-5. PubMed ID: 25817568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Botulinum Toxin in Raynaud Phenomenon: A Comprehensive Literature Review.
    Lawson O; Sisti A; Konofaos P
    Ann Plast Surg; 2023 Jul; 91(1):159-186. PubMed ID: 37450876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
    Motegi SI; Sekiguchi A; Saito S; Ishibuchi H; Kishi C; Yasuda M; Ishikawa O
    J Dermatol; 2018 Mar; 45(3):349-352. PubMed ID: 29164658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A treatment of Raynaud's phenomenon: a review.
    Iorio ML; Masden DL; Higgins JP
    Semin Arthritis Rheum; 2012 Feb; 41(4):599-603. PubMed ID: 21868066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.
    Uppal L; Dhaliwal K; Butler PE
    J Hand Surg Eur Vol; 2014 Oct; 39(8):876-80. PubMed ID: 24369360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin A Treatment for Primary and Secondary Raynaud's Phenomenon in Teenagers.
    Quintana Castanedo L; Feito Rodríguez M; Nieto Rodríguez D; Maseda Pedrero R; Chiloeches Fernández C; de Lucas Laguna R
    Dermatol Surg; 2021 Jan; 47(1):61-64. PubMed ID: 32371783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Bello RJ; Cooney CM; Melamed E; Follmar K; Yenokyan G; Leatherman G; Shah AA; Wigley FM; Hummers LK; Lifchez SD
    Arthritis Rheumatol; 2017 Aug; 69(8):1661-1669. PubMed ID: 28426903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.